Upcoming Patent Loss of Jakafi Highlights Portfolio Risks; Downgrading Incyte's Moat to None
We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...
manufacturingdigital5h
Top Ten: Manufacturing Apprenticeship Schemes in the UK
Its UK #NationalApprenticeshipWeek, so we've put together a list of our top ten manufacturing apprenticeship schemes led by ...
London midday: Stocks flat ahead of US inflation reading
London stocks were still flat by midday on Wednesday ahead of the latest US inflation reading. The FTSE 100 was steady at ...
London open: Stocks flat ahead of US inflation; Barratt Redrow surges
London stocks were flat in early trade on Wednesday as investors eyed the latest US inflation reading. At 0830 GMT, the FTSE ...
Indiatimes22h
GSK Pharma - GlaxoSmithKline Pharmaceuticals Share Price
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...